NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/06/2025
Voltar para busca
Dado oficial do USPTO
MYNAVCARE PATIENT SUPPORT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MYNAVCARE PATIENT SUPPORT
ST13
US500000097936772Classe
35, 36, 44, 45
Pedido
97936772
Registro
7819913
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
03/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 44, 45
Data de depósito
15/05/2023
Data de registro
03/06/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/06/2025
Última transação
03/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
31/05/2023
Primeiro uso no comércio
31/05/2023
Código do desenho
4
Tipo de titular
99
Localização do titular
Valby, DK
Examinador
GULIANO, ROBERT N
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Genmab A/S
Representantes
Max Vern Amster, Rothstein & Ebenstein LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Classe 36
Financial administration of patient reimbursement and patient financial assistance programsnamely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable servicesproviding financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance planspatient financial assistancepatient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Classe 44
Medical assistancenamely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancerautoimmune diseasesinflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care servicesnamely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical servicesprovision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Classe 45
Providing personal support services for patients and families of patients in connection to disease management and navigation through medical treatmentsemotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders in connection to disease management and reimbursement of medical expensescompanionshiphelp with medical formsemotional counseling and emotional support; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/06/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/05/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2025
ALIE
ASSIGNED TO LIE
25/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/02/2025
GNRT
NON-FINAL ACTION E-MAILED
13/02/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
13/02/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
23/01/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
23/01/2025
IUAF
USE AMENDMENT FILED
07/11/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/03/2024
PUBO
PUBLISHED FOR OPPOSITION
19/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/01/2024
GNRT
NON-FINAL ACTION E-MAILED
23/01/2024
CNRT
NON-FINAL ACTION WRITTEN
23/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/01/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/10/2023
GNRT
NON-FINAL ACTION E-MAILED
17/10/2023
CNRT
NON-FINAL ACTION WRITTEN
17/10/2023
DOCK
ASSIGNED TO EXAMINER
11/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/06/2023
NWAP
NEW APPLICATION ENTERED
18/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MYNAVCARE PATIENT SUPPORT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.